Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunoinflammatory and Synaptic Biomarkers in Bipolar Disorder: A Case-Control Study of OLFM4 and LRFN5

NCT07434414 is registered in ClinicalTrials.gov with Elazığ Mental Health and Diseases Hospital as lead sponsor.

NCT NCT07434414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07434414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunoinflammatory and Synaptic Biomarkers in Bipolar Disorder: A Case-Control Study of OLFM4 and LRFN5
Lead sponsor
Elazığ Mental Health and Diseases Hospital
Phase
Observational
Overall status
Completed
Start date
July 7, 2025
Completion date
January 2, 2026
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder (bd)